Tetrafluoroethylene (TFE), a compound used for the production of fluorinated polymers including polytetrafluoroethylene, increases the incidence of liver and kidney cancers and leukemia in rats and mice. This is the first time the cancer risk in humans has been explored comprehensively in a cohort mortality study that included all polytetrafluoroethylene production sites in Europe and North America at the time it was initiated. A jobexposure matrix was developed for TFE and ammonium perfluoro-octanoate, a chemical used in the polymerization process. National reference rates were used to calculate standardized mortality ratios (SMRs) and 95% confidence intervals. Among 4,773 workers ever exposed to TFE, we found a lower rate of death from most causes, as well as increased risks for cancer of the liver (SMR = 1.27; 95% confidence interval: 0.55, 2.51; 8 deaths) and kidney (SMR = 1.44; 95% confidence interval: 0.69, 2.65; 10 deaths) and for leukemia (SMR = 1.48; 95% confidence interval: 0.77, 2.59; 12 deaths). A nonsignificant upward trend (P = 0.24) by cumulative exposure to TFE was observed for liver cancer. TFE and ammonium perfluoro-octanoate exposures were highly correlated, and therefore their separate effects could not be disentangled. This pattern of findings narrows the range of uncertainty on potential TFE carcinogenicity but cannot conclusively confirm or refute the hypothesis that TFE is carcinogenic to humans.
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Tetrafluoroethylene (TFE; chemical formula: C 2 F 4 ; CAS Registry Number: 116-14-3) is a colorless water-insoluble gas used primarily as a monomer for the production of polytetrafluoroethylene (PTFE) or other fluorinated polymers and as a chemical intermediate for hexafluoropropylene synthesis (1) (2) (3) . PTFE has very useful properties and is used widely in industry and in consumer goods-for example, films and fibers, bearings and gaskets, nonstick coatings for cooking utensils, waterproof and breathable membranes for clothes, and protective coatings on carpets.
Chronic inhalation exposure to TFE has resulted in an increased tumor incidence in laboratory animals of both sexes. A 2-year bioassay in mice and rats exposed to TFE through inhalation showed clear evidence of carcinogenic activity of TFE in male F344/N rats, indicated by increased incidences of renal tubule neoplasms and hepatocellular neoplasms (4) . There was evidence of carcinogenic activity in female F344/N rats, indicated by increased incidences of renal tubule neoplasms, liver hemangiosarcomas, hepatocellular neoplasms, and mononuclear cell leukemia. In male and female B6C3F1 mice, carcinogenic activity was indicated by increased incidences of liver hemangiomas and hemangiosarcomas, hepatocellular neoplasms, and histiocytic sarcomas. Slight increases in the incidences of mononuclear cell leukemia and testicular interstitial cell adenomas in male rats might have been related to exposure to TFE.
On the basis of these studies, the International Agency for Research on Cancer (IARC) concluded that there was sufficient evidence in experimental animals for the carcinogenicity of TFE and, in the absence of epidemiologic data, classified it in group 2B (possibly carcinogenic to humans) (2). TFE shows no activity in standard assays for mutagenicity. Also, the nephrotoxic reactive metabolites produced via the hepatic glutathione transferase and renal β-lyase pathways showed no evidence of mutagenic activity when tested in modified Ames assays involving metabolic activation with S9 produced from rat kidney (5) . A plausible mechanism of action for the development of renal tumors in rats exposed to TFE is based on the metabolism of TFE by the glutathione pathway. However, the mechanism of action of the carcinogenic effects observed in the livers of mice and rats exposed to TFE is not fully understood. No evidence has been found for a role of the glutathione pathway in the development of hemangiosarcomas in rodents. Attempts to demonstrate a mechanism of action based on its oxidative metabolism via cytochrome P450 were inconclusive (6) .
The only significant route of human exposure is inhalation. The American Conference of Governmental Industrial Hygienists established an 8-hour threshold limit value-timeweighted average of 2 ppm (1 ppm = 4.1 mg/m 3 ) for occupational settings and recommended a rating of A3 (confirmed animal carcinogen with unknown relevance to humans) (7) .
Data from studies in animals suggest that the outcomes of primary interest in studying the possible risk to humans are liver cancer, kidney cancer, leukemia, nephritis, and nephrosis. Studying these outcomes was the main goal of this TFE Multicenter Mortality Study, in which we investigated the cause-specific mortality rate between 1950 and 2008 of workers potentially exposed to TFE during its manufacture and its polymerization into PTFE between 1950 and 2002. At the time it was initiated, the study included all 6 PTFE production sites in Europe and North America. Because polymerization involves the use of ammonium perfluoro-octanoate (APFO), a compound with a carcinogenic potential (8) (9) (10) , the mortality rate in relation to exposure to this potential confounder was also examined.
MATERIALS AND METHODS

Study population
After a feasibility study, 4 companies with 7 production sites in the United States and Europe agreed to participate. The 6 production sites in Gendorf (Germany), Dordrecht (the Netherlands), Spinetta Marengo (Italy), Thornton Cleveleys (United Kingdom), Bayonne (New Jersey, United States), and Parkersburg (West Virginia, United States), which employed the entire European/US TFE manufacturing population, were included in the study. A plant in Fayetteville, North Carolina, that started operations in 1979 and employed only 31 workers (29 men, 2 women) in TFE processes was excluded. At 3 production sites (Spinetta Marengo, Thornton Cleveleys, and Bayonne), all workers of either sex who had ever worked in a plant with potential exposure to TFE were included. At the others, only workers with a minimum of 1 year (Gendorf and Dordrecht) or 6 months (Parkersburg) of potentially exposed employment were included. For these latter production sites, this choice was motivated by uncertainties in the enumeration of short-term workers and incompleteness of their work history records. Short-term workers include part-time workers and those working in support roles before assignment. Because TFE production involves highly technical job assignments and extensive training, short-term workers were unlikely to have held a position in TFE divisions.
Exposure assessment
Exposure assessment was undertaken for workers exposed to TFE and APFO, a compound used as a polymerization aid in the manufacture of PTFE. TFE is flammable and can present an explosive risk, so production occurs mainly within closed systems. The main potential TFE exposure is through leaks, from opening autoclaves in the polymerization area or from decomposition of PTFE. The sparse measurement data available from the plants suggest that TFE exposure levels could have been up to a few parts per million. APFO, the ammonium salt of perfluorooctanoic acid (PFOA; also known as C8) readily dissociates to form PFOA in aqueous solutions, and thus the 2 terms often are used interchangeably. In the absence of suitable measurements, a method of reconstructing exposure was developed (3). The final output was a job-exposure matrix with yearly semiquantitative estimates (in arbitrary units) of TFE and APFO exposure for relevant job titles at each production site, from the start of TFE production to 2002. Plant-level information on potential exposure (yes/no) to asbestos and to vinyl chloride monomer was also collected.
The TFE subcohort from Parkersburg, West Virginia, in this multicenter study included 2,379 individuals with at least 6 months of employment in the TFE production unit during the period 1950-2002. On further review and categorization of the job titles by the exposure assessors, they were classified as exposed (1,554 workers), unexposed (820 workers), or having unknown exposure (5 workers) because of missing work history records. The TFE subcohort is a subset of the entire occupational cohort of about 6,000 workers ever employed at the Parkersburg production site in any of 5 production areas between 1948 and 2002. The plant-wide mortality rate had been evaluated previously by Leonard et al. (11) and was recently re-assessed in relation to estimated cumulative serum PFOA levels (12, 13) . In particular, in Germany, the Netherlands, and Italy, vital status was ascertained through contact of population registries. In Germany, death certificates were requested from community health departments, and underlying causes of death were coded by professional nosologists according to the International Classification of Diseases (ICD), Ninth Revision. In Italy, ICD-9 codes were retrieved from local health unit files; when codes were not available, death certificates were obtained and coded by personnel of the local health unit. In the Netherlands, causes of death and relevant ICD codes (ICD-9 before 1996 and ICD-10 for deaths that occurred thereafter) were retrieved from the Central Bureau of Statistics. In the United Kingdom, vital status was ascertained from the Medical Research Information Service of the National Health Service. The underlying cause of death was coded by the Office of Population Censuses and Surveys to the ICD-10. For the Parkersburg, West Virginia, subcohort, the Social Security numbers for each member were submitted to the Social Security Administration for confirmation of vital status. Causes of death were determined through the DuPont Epidemiology Registry, which tracks vital status for active and pensioned workers from 1957 through the present via pension benefit reports filed with the company and validated by receipt of a death certificate from family members claiming a pension (14, 15) . For workers confirmed to be deceased by the Social Security Administration from 1979 through the present, cause of death was ascertained from the US National Death Index. This approach was applied previously for the plant-wide cohort study (11) and was subsequently validated (12) . For the Bayonne, New Jersey, subcohort, the same approach was used to ascertain vital status and cause of death. For deaths before 1979, the New Jersey State Department of Health and Senior Services provided causes of death. For the Parkersburg and Bayonne subcohorts, ICD-9 (for deaths before 2000) and ICD-10 codes were used. Each center obtained approval from the relevant institutional review board.
Statistical analysis
We selected workers with at least 1 job period between the start of TFE/PTFE production and December 31, 2002 (end of exposure assessment). For each worker, we calculated person-years at risk from the time he had both satisfied the conditions for entry to the cohort (i.e., person-years before the minimum employment requirement in 3 subcohorts were excluded) and acquired the relevant exposure. Follow-up ended on date of death, loss to follow-up, or study end, whichever came first (16). Person-years accumulated before the worker held a job involving TFE exposure were considered non-TFEexposed person-years in selected analyses (17) . We merged individual occupational histories with the plant-specific jobexposure matrix to calculate time-varying cumulative TFE exposure (16), categorized into tertiles calculated for deaths from all causes.
For 4 production sites (Gendorf, Spinetta Marengo, Dordrecht, and Parkersburg), 306 workers had incomplete job histories. Most of them (n = 256) were in the Gendorf subcohort, for which we used the following approach. If the missing job was between 2 identical jobs, we assigned the known job to the missing one. For workers with only 2 jobs, we assumed that the missing job was the same as the known one. For workers with a missing job between 2 known different jobs, the TFE exposure (estimated through the jobexposure matrix) was linearly interpolated and assigned to the years spent in the missing job. In case of several consecutive missing jobs, we assigned a known job to only an adjacent missing job, and we linearly interpolated the TFE/APFO exposure for the rest of the jobs. In the Dordrecht subcohort, for whom the last job was unknown for 23 workers, we assumed the exposure was equal to that in the previous job. We followed similar approaches for the Spinetta Marengo and Washington subochorts, where very few (4 and 3, respectively) workers had an incomplete job history. For 2 production sites (Dordrecht and Thorton Cleveleys) the never-exposed workers were excluded a priori (that is, before merging with the jobexposure matrix to determine TFE exposure). Overall, the large majority of never-exposed workers were from a single site (Parkersburg). In other subcohorts, the never-exposed workforce comprised white-collar workers who might not have been comparable to production workers in terms of nonoccupational determinants of mortality risk. For these reasons, the main analyses focused on workers exposed to TFE.
We compared the cause-specific observed mortality rate of each subcohort with the rate that would be expected according to national mortality reference rates for males in 5-year calendar periods and 5-year age groups. Rates for England and Wales were used for the United Kingdom, and rates for whites were used for the United States. We calculated standardized mortality ratios (SMRs) as the ratio of observed to expected deaths, with their exact 95% confidence intervals based on the Poisson distribution (18) . For selected causes (all causes, all cancers, and lung cancer; cancer sites of a priori interest; cancers with SMR > 1.00 in the overall analysis; and liver and renal nonmalignant diseases), analyses by length of exposure, time since first exposure, and cumulative exposure to TFE were performed. Two-sided χ 2 tests for linear trend were carried out by treating the variable as ordinal (19) . We performed the following complementary SMR analyses: 1) using as reference the regional mortality rates of Bavaria (Germany), Piedmont (Italy), Lancashire (United Kingdom), and New Jersey and West Virginia (United States); 2) including only workers with complete job histories; and 3) assessing cumulative exposure to TFE after inclusion of plant workers never exposed to TFE. For workers exposed to APFO, we performed an overall SMR analysis and an analysis by cumulative exposure to APFO. A joint analysis by cumulative exposure to TFE and APFO was also performed. Statistical analyses were performed in Stata, version 12 (20) .
RESULTS
The number of women eligible for inclusion was 778, of whom 683 (87.8%) were employed at the Parkersburg, West Virginia, site; numbers at the other sites ranged from 0 to 50. Among the women, we recorded 16 deaths, with no unusual mortality pattern (results not shown). In the following analyses, female workers are not included.
After exclusion of 101 male workers for whom date of birth was missing and 21 workers for whom date of hire was missing, the number of male workers eligible for analysis was 5,879 ( Table 1 ). The year of termination of follow-up for individual sites ranged from 2001 to 2008. Ascertainment of vital statuswas98.8%complete.Thenumberofdeathswithunknown cause was small. The number of workers ever exposed to TFE according to the job-exposure matrix amounted to 4,773 (81.2%) and the number of those never exposed to 1,081 (18.4%). The total number of person-years at risk was 148,843; TFE-exposed person-years amounted to 108,862 (73.1%).
Job histories were completely missing for only 25 workers (0.4%). The number of workers with incomplete job histories was 306 (5.2%). The majority of these were in the German subcohort, in which the proportion of workers with incomplete job history was about one third, but the proportion of working years in unknown jobs was lower (11.9%), which indicates that many of those jobs were of short duration. Web Table 1 , available at http://aje.oxfordjournals.org/, shows statistics for selected time-related variables for the 4,773 TFE-exposed workers. The oldest subcohort was in the United Kingdom. The subcohorts with the highest lengths of exposure were in the Netherlands and in Italy; in the Bayonne, New Jersey, subcohort, the median length of exposure was only 1.1 year. The overall average time since first exposure was 22.3 (range, 16.6-28.8) years. Overall, cumulative exposure to TFE had a mean of 519 and a median of 191 arbitrary unit-years.
In comparison with national rates, the mortality rate from all causes, all cancers, and many cancer and noncancer causes among the TFE-exposed workers was lower than expected (Table 2) . Elevated SMRs were found for cancers of the liver and kidney and for leukemia-the cancer causes of a priori interest. Deaths from nephritis and nephrosis (3 from chronic and 1 from unspecified renal failure), also of a priori interest, were below expectation. Liver cirrhosis was not in excess overall but was increased in the subcohort in Bayonne (15 observed deaths vs. 3.6 expected deaths). The SMRs calculated with regional rates for reference were quite similar to those calculated with national rates: 1.32 for liver cancer, 1.51 for kidney cancer, and 1.51 for leukemia.
Among those not exposed to TFE (including 26,515 person-years from 1,081 never-exposed workers and 12,817 person-years accumulated by exposed workers before start of TFE exposure), we found a markedly lower rate of death from all causes (133 observed deaths vs. 238.2 expected deaths) and all cancers (38 observed deaths vs. 61.1 expected deaths). There were no deaths from liver cancer (1.6 expected), leukemia (2.5 expected), or liver cirrhosis (7.5 expected). There were 3 deaths from pancreatic cancer (2.9 expected), 2 from kidney cancer (1.7 expected), and 1 from nephritis and nephrosis (1.7 expected). We recorded 7 deaths among the 25 workers (649 person-years) with unknown TFE exposure, with no unexpected pattern. Table 3 shows SMRs by categories of cumulative exposure to TFE (in arbitrary unit-years). Among the 4,773 workers exposed to TFE, no definite exposure-response relationships were apparent for all-cause or all-cancer deaths. For liver cancer, there was a 2-fold elevation of mortality rate among workers with the highest estimated cumulative exposure; the P value for trend, however, was high (P = 0.24). There was no trend with cumulative TFE exposure for deaths from kidney cancer and leukemia. The elevated mortality rate from liver cirrhosis in the low-exposure category was attributable to the Bayonne subcohort (12 observed deaths vs. 2.4 expected deaths) and caused a clear negative trend in the whole cohort. No increases were observed for nephritis or nephrosis. The rate of death from pancreatic cancer was elevated in the medium-and high-exposure categories (P for trend = 0.21). The rate of death from lung cancer remained well below expectation in all categories. Esophageal cancer was above expectation only in the lowexposure category. When the nonexposed person-years were added into the analysis, the only notable difference was a P value of 0.06 for test for trend for liver cancer. When we excluded person-years and deaths of workers with 1 or more unknown jobs (250 ever-and 56 never-exposed workers), the results changed negligibly (results not shown).
Analyses by length of exposure to TFE for selected causes among workers ever exposed to TFE (Table 4) showed negative trends for deaths from all cancers and lung cancer. Clear-cut patterns were not seen for any of the other cancer sites or types. The modest excess mortality due to liver cirrhosis in the lower-exposure category was driven by the Bayonne subcohort, in which we observed 13 deaths (2.9 expected). Mortality rate by time since first exposure to TFE (Table 5) did not show any definite trend.
Of the 4,773 TFE-exposed workers, 568 (11.9%) were estimated to have never been occupationally exposed to APFO, whereas 4,205 (88.1%) were exposed to both compounds during TFE polymerization. There were no workers exposed to APFO but not to TFE. Results of analyses for exposure to APFO showed patterns closely comparable to those seen for TFE, both Table 2 ) and in the analysis by cumulative exposure (Web Table 3 ). There was a high concordance of results by cumulative exposure to TFE and APFO, as can be inferred from the small number of observed and expected deaths in cells off the diagonals (Web Table 4 ), thus rendering difficult the evaluation of their separate associations with mortality rate. 
DISCUSSION
This multicenter study examined for the first time the cancer risk in the entire European and North American workforce exposed to TFE during its synthesis and polymerization processes. Increased SMRs were estimated for cancers of a priori interest according to experiments in animals-specifically liver cancer, kidney cancer, and leukemia; however, SMR estimates were imprecise (with large confidence intervals), and the exposure-response trends were not significant.
Strengths of this study were the clearly defined criteria for identifying and assembling the cohort, the large study base, the common strategy for exposure assessment, the almost complete follow-up and determination of causes of death, and the comparison of mortality rates with local and national rates. Limitations were the low power to detect a significant doubling of mortality rate for rare cancers (as calculated in the feasibility phase); an unknown degree of nondifferential misclassification of TFE exposure estimates; and the semiquantitative nature of exposure assessment, which precludes extrapolation of quantitative exposure-response relationships to other settings.
For the cancers of interest, several risk factors are known, which, at least in principle, might have played a confounding role (21, 22) . Unfortunately, little information was available for those factors for individual cohort members. Although confounding by alcohol consumption cannot be excluded, the different mortality rate patterns for liver cirrhosis (excess mortality rate confined to 1 single subcohort with many shortterm workers) and liver cancer make confounding by alcohol an unlikely explanation of our findings. In only 2 production sites (Gendorf and Thornton Cleveleys), previous exposure to vinyl chloride monomer might have affected part of the workforce before employment in the TFE/PTFE plants. The use of regional reference data should have controlled, at least in part, for differences in the prevalence of hepatitis virus infection between the cohort and the reference population. Tobacco smoking does not seem to carry a large enough relative risk of liver cancer to have been an important confounder (22, 23) . We found no mortality rate excesses for the main smokingrelated cancers (i.e., lung, larynx, and bladder) or for respiratory diseases, except in 1 subcohort (Bayonne) with a large proportion of short-term workers. Therefore, confounding by smoking seems unlikely for kidney cancer mortality rate. For leukemia, established or suspect exogenous risk factors include benzene, ionizing radiation, antineoplastic drugs, formaldehyde, 1,3-butadiene, and ethylene oxide (21) . No information on possible previous exposure to those risk factors was available. Among other causes of death, we found modest excesses for esophageal and pancreatic cancers but with no clear pattern of association with TFE exposure indices. Although some studies have found an association between pancreatic cancer and occupational or environmental exposures (24, 25) , no occupational risk factors have been firmly established for these cancers (21, 22, 26) , and the possible role of lifestyle factors could not be assessed.
APFO has been shown to induce liver, testicular Leydig cell, and pancreatic acinar cell tumors in rodents and has been linked with some of the investigated outcomes (including kidney cancer) in humans (8) (9) (10) (11) (12) (13) (27) (28) (29) . Hence, in the present study it represented a potential confounder because it was correlated with exposure to TFE. When APFO was adopted as the exposure variable, the findings were substantially the same as in the analyses by TFE exposure, and it was not possible to disentangle the separate associations of occupational exposure to TFE and APFO with mortality rate; this was because the great majority of the workforce was exposed to both, and the exposure estimates for the 2 compounds were highly correlated (Spearman's ρ = 0.72) (3) . A recent mortality study among the entire Parkersburg, West Virginia, cohort of almost 6,000 workers with potential (direct, indirect, or background) exposure to PFOA found an elevated mortality rate from chronic renal disease and positive associations between estimated cumulative serum PFOA levels and both malignant and nonmalignant renal diseases (12, 13) . In summary, risk elevations, albeit with limited evidence for exposure-response relations, were seen for liver cancer, kidney cancer, and leukemia-all outcomes suggested by experimental studies. Liver cancer showed an upward trend, although not significant, by increasing category of cumulative exposure. None of the potential confounders that were addressed emerged as a possible alternative explanation for the findings. These findings could have biological plausibility for humans. Data from animal studies provided clear evidence of TFE carcinogenicity in 2 species (4), and TFE metabolites induce changes potentially relevant to tumorigenesis (30) . The pattern of findings in the present large study substantially narrows the range of uncertainty on the possible cancer risk entailed in working in TFE synthesis and polymerization, and it justifies continuing efforts to minimize exposure, which has already dropped considerably over the years (3) . Nevertheless, the findings could neither conclusively confirm nor refute the hypothesis that TFE poses a carcinogenic risk to human beings. If a cancer hazard exists, then the risk is small, even in workers with relatively high exposure. To address remaining gaps in knowledge, extended followup of this cohort and studies with quantitative exposure assessment in similar cohorts are warranted.
